drugset / Trial / NCT00139932
Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272)
Phase 4
Completed
255 enrolled
Merck Sharp & Dohme LLC
Integrated Therapeutics Group · collabNovartis · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is being conducted to determine if the co-administration of formoterol fumarate and tiotropium bromide is more effective than the use of tiotropium bromide alone in patients with COPD.
Timeline
- Start
- 2005-09-01
- Primary completion
- 2006-11-21
- Completion
- 2006-11-21
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Formoterol | Other / unclassified | 12 ug | — |